Primary Human Tumor Grafts
|
Charles River Discovery Services is aggressively building a primary human tumor graft portfolio and we expect to have validated models available in 2011. This platform is designed to deliver:
- Early passage cryopreservation
- Broad panels of 10 solid tumors
- Sensitivity and resistance profiles
- Expression and mutation profiles
Tumor samples will be available for custom analysis. For more information about our primary human tumor grafts, please contact us at 1.877.CRIVER.1 or askcharlesriver@crl.com.
|
|
|
primary human tumor graft, tumor graft, tumor grafts, tumors, tumor, oncology
Primary Human Tumor Grafts | Charles River Discovery Services
Charles River is aggressively building a primary human tumor graft portfolio. This platform is designed to deliver early passage cryopreservation, broad panels of 10 solid tumors, sensitivity and resistance profiles, and expression and mutation profiles.